Possible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infant
dc.authorid | 113274 | en_US |
dc.contributor.author | Elkıran, Özlem | |
dc.contributor.author | Karakurt, Cemşit | |
dc.contributor.author | Koçak, Gülendam | |
dc.contributor.author | Tabel, Yılmaz | |
dc.contributor.author | Güngör, Serdal | |
dc.date.accessioned | 2017-08-23T10:39:51Z | |
dc.date.available | 2017-08-23T10:39:51Z | |
dc.date.issued | 2015 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Fluconazole, an azole antifungal agent, inhibits the fungal cytochrome P450 enzyme. Although in vitro data show that fluconazole is not a potent inhibitor of mammalian P450 enzymes, hyperkalemia secondary to adrenal insufficiency associated with fluconazole has been described rarely [1–3]. However, life-threatening severe hyperkalemia related to administration of intravenous fluconazole without adrenal suppression has not been reported before. | en_US |
dc.identifier.citation | Elkıran, Ö. Karakurt, C. Koçak, G. Tabel, Y. Güngör, S. (2015). Possible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infant . Arch Med Sci, 11(1), 235–236. | en_US |
dc.identifier.doi | 10.5114/aoms.2015.49215 | en_US |
dc.identifier.endpage | 236 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 235 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/7684 | |
dc.identifier.volume | 11 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Arch Med Sci | en_US |
dc.relation.ispartof | Arch Med Sci | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Possible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infant | en_US |
dc.type | Article | en_US |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.71 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: